No Data
Novo Nordisk's Sales Growth at Risk Over U.S. Price Erosion -- Market Talk
Why Is Novo Nordisk A/S (NVO) Among Louis Navellier's Top Stock Picks Heading Into 2025?
Novo Nordisk A/S (NVO): A Bull Case Theory
What the Options Market Tells Us About Novo Nordisk
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Aurisco Pharmaceutical (605116.SH): Currently, there is no collaboration with Novo-Nordisk A/S.
On November 28, Glonghui reported that aurisco pharmaceutical (605116.SH) stated on the investor interaction platform that the company is actively developing the market for the active pharmaceutical ingredient semaglutide, and currently has no collaboration with novo-nordisk a/s.
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
a bit late with my European Morning News see post ...
